This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

In September 2024, Athira announced topline results from the LIFT-AD Phase 2/3 clinical trial of fosgonimeton in mild-to-moderate Alzheimer’s disease. The study did not meet its primary or key ...

Indivior PLC the Board of Directors (the "Board") of Indivior plc ("Indivior" or the "Company") notes the publication today of a letter from Oaktree Capital Management LP ("Oaktree") to the Board of ...

The marquee fundraiser of the Women's Guild Cedars-Sinai is set to take place at the Beverly Wilshire, a Four Season Hotel in ...

The former Spirit head passed away on Nov. 5 from amyotrophic lateral sclerosis, a degenerative illness also known as ALS, or ...

Ben Baldanza, who was perhaps best known in the aviation world for helping to pioneer discount air travel at the US's Spirit Airlines, has died aged 62. An obituary has been posted on Baldanza’s ...

The University of Ghana (UG), in collaboration with Google Research Africa and the University College of London’s (UCL) ...

Neurosense Therapeutics (NASDAQ:NRSN) is developing novel treatments for neurodegenerative diseases like amyotrophic lateral ...

Former Spirit Airlines CEO and airline industry communicator Ben Baldanza passed away on November 5, 2024, at the age of 62.

"According to the latest study from BCC Research, Antibody Drugs: Technologies and Global Markets is expected to grow from $242.6 billion in 2024 to $412.1 billion ...